Reuters logo
BRIEF-PTC THERAPEUTICS ANNOUNCES DATA FROM PART 1 OF SUNFISH TRIAL
October 3, 2017 / 2:38 PM / 2 months ago

BRIEF-PTC THERAPEUTICS ANNOUNCES DATA FROM PART 1 OF SUNFISH TRIAL

Oct 3 (Reuters) - PTC Therapeutics Inc:

* RG7916 INCREASED SMN PROTEIN PRODUCTION IN SUNFISH CLINICAL TRIAL IN PATIENTS WITH TYPE 2/3 SPINAL MUSCULAR ATROPHY

* PTC THERAPEUTICS INC - RG7916 REMAINS WELL-TOLERATED IN PATIENTS AT ALL DOSES AND THERE HAVE BEEN NO DRUG-RELATED SAFETY FINDINGS LEADING TO WITHDRAWAL​

* PTC THERAPEUTICS INC SAYS ANNOUNCED DATA FROM PART 1 OF SUNFISH TRIAL OF RG7916 IN TYPE 2/3 SPINAL MUSCULAR ATROPHY PATIENTS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below